It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Investment analysts at B. Riley lifted their Q2 2025 earnings per share (EPS) estimates for Digi International in a research report issued on Thursday, February 6th. B. Riley analyst J. Nichols now ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The state Senate is expected to quickly agree with Jan. 27 House vote, which would send the request to Washington ...

Experts said millions of people across the country are prescribed a medicine for moderate to severe acute pain each year, so Journavx can help establish a new level of care. The FDA reports this ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at least as effective and costs only 50 cents a pill? They will if the generic ...

PHILADELPHIA (AP) — A.J. Brown lingered with some of his Eagles teammates outside the Los Angeles Lakers' locker room like any fan who had even a hint of a chance to hug it out with LeBron James.